Fuller & Thaler Asset Management Inc. Boosts Stake in Align Technology, Inc. $ALGN

Key Points

• Fuller & Thaler Asset Management Inc. increased its stake in Align Technology by 157.8% during the first quarter, acquiring a total of 4,588 shares valued at approximately $729,000.
• Multiple institutional investors have recently adjusted their positions in Align Technology, with notable increases from Teacher Retirement System of Texas and Schonfeld Strategic Advisors LLC.
• Align Technology has faced challenges with its earnings, reporting an EPS of $2.49 for the last quarter, which missed analyst expectations, and it has set a $1 billion stock repurchase plan indicating the board's belief in the stock's undervaluation.

Fuller & Thaler Asset Management Inc. grew its stake in shares of Align Technology, Inc. (NASDAQ:ALGN - Free Report) by 157.8% in the 1st quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 4,588 shares of the medical equipment provider's stock after buying an additional 2,808 shares during the period. Fuller & Thaler Asset Management Inc.'s holdings in Align Technology were worth $729,000 at the end of the most recent reporting period.

A number of other institutional investors also recently made changes to their positions in ALGN. Teacher Retirement System of Texas acquired a new stake in shares of Align Technology during the first quarter valued at $1,647,000. Asset Management One Co. Ltd. lifted its holdings in Align Technology by 14.5% in the 1st quarter. Asset Management One Co. Ltd. now owns 31,624 shares of the medical equipment provider's stock valued at $5,024,000 after purchasing an additional 4,009 shares in the last quarter. Schonfeld Strategic Advisors LLC boosted its stake in shares of Align Technology by 1,679.5% during the 4th quarter. Schonfeld Strategic Advisors LLC now owns 35,110 shares of the medical equipment provider's stock worth $7,321,000 after purchasing an additional 33,137 shares during the last quarter. American Assets Inc. purchased a new stake in shares of Align Technology during the fourth quarter worth about $417,000. Finally, Janney Montgomery Scott LLC grew its holdings in shares of Align Technology by 48.9% during the first quarter. Janney Montgomery Scott LLC now owns 10,120 shares of the medical equipment provider's stock worth $1,608,000 after buying an additional 3,325 shares in the last quarter. 88.43% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of analysts recently issued reports on ALGN shares. Stifel Nicolaus decreased their target price on shares of Align Technology from $275.00 to $200.00 and set a "buy" rating on the stock in a research report on Thursday, July 31st. Evercore ISI increased their target price on Align Technology from $200.00 to $220.00 and gave the stock an "outperform" rating in a research report on Wednesday, July 9th. Needham & Company LLC reissued a "hold" rating on shares of Align Technology in a research note on Thursday, May 1st. HSBC cut Align Technology from a "buy" rating to a "hold" rating and lowered their price target for the company from $290.00 to $170.00 in a report on Friday, April 25th. Finally, Mizuho set a $210.00 price objective on shares of Align Technology in a report on Thursday, July 31st. One research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, five have assigned a Hold rating and one has given a Sell rating to the company's stock. According to MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus price target of $215.00.

Insider Activity at Align Technology

In other Align Technology news, CEO Joseph M. Hogan bought 7,576 shares of Align Technology stock in a transaction that occurred on Friday, August 1st. The shares were acquired at an average price of $131.49 per share, for a total transaction of $996,168.24. Following the acquisition, the chief executive officer owned 184,945 shares of the company's stock, valued at $24,318,418.05. The trade was a 4.27% increase in their position. The acquisition was disclosed in a filing with the SEC, which can be accessed through this link. Corporate insiders own 0.66% of the company's stock.

Align Technology Price Performance

NASDAQ ALGN opened at $143.58 on Thursday. Align Technology, Inc. has a 1-year low of $127.70 and a 1-year high of $262.87. The firm has a market capitalization of $10.41 billion, a P/E ratio of 24.21, a P/E/G ratio of 1.62 and a beta of 1.61. The business's 50-day simple moving average is $176.75 and its 200-day simple moving average is $177.98.

Align Technology (NASDAQ:ALGN - Get Free Report) last posted its quarterly earnings results on Wednesday, July 30th. The medical equipment provider reported $2.49 EPS for the quarter, missing the consensus estimate of $2.57 by ($0.08). The business had revenue of $1.01 billion during the quarter, compared to analysts' expectations of $1.06 billion. Align Technology had a net margin of 11.04% and a return on equity of 13.36%. The company's quarterly revenue was down 1.6% on a year-over-year basis. During the same quarter in the previous year, the business posted $2.41 EPS. Align Technology has set its Q3 2025 guidance at EPS. On average, equities research analysts expect that Align Technology, Inc. will post 7.98 EPS for the current fiscal year.

Align Technology declared that its board has approved a stock repurchase plan on Tuesday, May 6th that authorizes the company to repurchase $1.00 billion in outstanding shares. This repurchase authorization authorizes the medical equipment provider to repurchase up to 7.9% of its shares through open market purchases. Shares repurchase plans are usually a sign that the company's board of directors believes its stock is undervalued.

Align Technology Company Profile

Align Technology, Inc designs, manufactures, and markets Invisalign clear aligners, and iTero intraoral scanners and services for orthodontists and general practitioner dentists in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers comprehensive products, including Invisalign comprehensive package that addresses the orthodontic needs of younger patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of six and ten years, which is a mixture of primary/baby and permanent teeth.

Want to see what other hedge funds are holding ALGN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Align Technology, Inc. (NASDAQ:ALGN - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.